Literature DB >> 25385857

Cysticercosis-related hospitalizations in the United States, 1998-2011.

Kaitlin A O'Keefe1, Mark L Eberhard2, Shira C Shafir2, Patricia Wilkins2, Lawrence R Ash2, Frank J Sorvillo2.   

Abstract

Cysticercosis has become increasingly recognized as an important infection in the United States in recent decades. Despite its potential impact, there is a lack of comprehensive information on the nationwide burden of disease. To better define the burden of cysticercosis in the United States, we analyzed in-patient records using the Nationwide Inpatient Sample for 1998-2011 to estimate cysticercosis-related hospitalizations and patient/institutional characteristics. There were an estimated 33,060 (95% confidence interval [95% CI] = 29,610.5-36,510.3) cysticercosis-related hospitalizations nationwide, representing a hospitalization rate of 8.03 per million population. The highest proportion of cases were male (54.8%), Hispanic (62.0%), aged 18-44 (58.8%), and occurred in the West (45.1%). An estimated 459 deaths occurred, representing an in-hospital case-fatality rate of 1.4%. These findings indicate the burden of cysticercosis-related hospitalizations in the United States is considerable and may be greater than currently appreciated. Cysticercosis should be a nationally reportable disease. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2014        PMID: 25385857      PMCID: PMC4347341          DOI: 10.4269/ajtmh.14-0506

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Neurocysticercosis in nonendemic countries: time for a reappraisal.

Authors:  Oscar H Del Brutto; Héctor H García
Journal:  Neuroepidemiology       Date:  2012-08-22       Impact factor: 3.282

2.  Cysticercosis: first 12 months of reporting in California.

Authors:  K L Ehnert; R R Roberto; L Barrett; F J Sorvillo; G W Rutherford
Journal:  Bull Pan Am Health Organ       Date:  1992

3.  A proposal to declare neurocysticercosis an international reportable disease.

Authors:  G Román; J Sotelo; O Del Brutto; A Flisser; M Dumas; N Wadia; D Botero; M Cruz; H Garcia; P R de Bittencourt; L Trelles; C Arriagada; P Lorenzana; T E Nash; A Spina-França
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

4.  Cysticercosis in Los Angeles County.

Authors:  F O Richards; P M Schantz; E Ruiz-Tiben; F J Sorvillo
Journal:  JAMA       Date:  1985-12-27       Impact factor: 56.272

Review 5.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

6.  Neurocysticercosis in an Orthodox Jewish community in New York City.

Authors:  P M Schantz; A C Moore; J L Muñoz; B J Hartman; J A Schaefer; A M Aron; D Persaud; E Sarti; M Wilson; A Flisser
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

7.  Seroprevalence of antibodies against Taenia solium cysticerci among refugees resettled in United States.

Authors:  Seth E O'Neal; John M Townes; Patricia P Wilkins; John C Noh; Deborah Lee; Silvia Rodriguez; Hector H Garcia; William M Stauffer
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

8.  Cysticercosis-related deaths, California.

Authors:  Frank J Sorvillo; Lawrence Portigal; Christopher DeGiorgio; Lisa Smith; Stephen H Waterman; George W Berlin; Lawrence R Ash
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

9.  Neurocysticercosis in Oregon, 1995-2000.

Authors:  John M Townes; Christopher J Hoffmann; Melvin A Kohn
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

10.  Neglected parasitic infections in the United States: cysticercosis.

Authors:  Paul T Cantey; Christina M Coyle; Frank J Sorvillo; Patricia P Wilkins; Michelle C Starr; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2014-05       Impact factor: 2.345

View more
  13 in total

Review 1.  Cervical Lymphatic Filariasis in a Pediatric Patient: Case Report and Database Analysis of Lymphatic Filariasis in the United States.

Authors:  Jonathan C Simmonds; Michael K Mansour; Walid I Dagher
Journal:  Am J Trop Med Hyg       Date:  2018-05-24       Impact factor: 2.345

2.  Survey of Obstetrician-Gynecologists in the United States About Taeniasis and Cysticercosis.

Authors:  Rebecca L Hall; Britta Anderson; Jay Schulkin; Paul T Cantey; Susan P Montgomery; Jeffrey L Jones
Journal:  Am J Trop Med Hyg       Date:  2016-11-14       Impact factor: 2.345

Review 3.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

4.  Hospitalization for Chagas disease, dengue, filariasis, leishmaniasis, schistosomiasis, strongyloidiasis, and Taenia solium taeniasis/cysticercosis, Italy, 2011-2016.

Authors:  Marta Tilli; Annarita Botta; Alessandro Bartoloni; Giampaolo Corti; Lorenzo Zammarchi
Journal:  Infection       Date:  2020-05-16       Impact factor: 3.553

5.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

6.  Successful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model.

Authors:  Armando E Gonzalez; Javier A Bustos; Hector H Garcia; Silvia Rodriguez; Mirko Zimic; Yesenia Castillo; Nicolas Praet; Sarah Gabriël; Robert H Gilman; Pierre Dorny
Journal:  Am J Trop Med Hyg       Date:  2015-09-21       Impact factor: 2.345

7.  Evaluating Healthcare Claims for Neurocysticercosis by Using All-Payer All-Claims Data, Oregon, 2010-2013.

Authors:  Robert H Flecker; Seth E O'Neal; John M Townes
Journal:  Emerg Infect Dis       Date:  2016-12       Impact factor: 6.883

Review 8.  Mapping occurrence of Taenia solium taeniosis/cysticercosis and areas at risk of porcine cysticercosis in Central America and the Caribbean basin.

Authors:  Uffe Christian Braae; Brecht Devleesschauwer; Fortune Sithole; Ziqi Wang; Arve Lee Willingham
Journal:  Parasit Vectors       Date:  2017-09-18       Impact factor: 3.876

9.  Neurocysticercosis in Pregnancy.

Authors:  Camille Webb; Mauricio La Rosa; Gayle Olson; Miguel Cabada
Journal:  AJP Rep       Date:  2018-04-09

10.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2018-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.